A row of sleek unbranded GLP-1 medication injection pens and a small clear medication vial arranged on a clean white clinical surface under soft studio lighting, with a faint out-of-focus line graph suggested in the background.

GLP-1 Pharmacokinetics: Half-Life, Steady State & Why Dosing Schedules Work

Updated 2026-06-16T00:00:00.000Z18 min read · 4,869 words

If you have ever wondered why Ozempic is a once-a-week shot, why Victoza is a daily one, and why your body's own GLP-1 hormone disappears in about a minute, the answer is the same in every case: pharmacokinetics, the science of what the body does to a drug over time. The single number that explains most of it is the half-life, and once it clicks, every GLP-1 dosing schedule starts to make sense.

This is a cross-cutting science hub, not a single-drug page. It explains the pharmacokinetic concepts that sit underneath the whole GLP-1 class, the same drugs that dominate the ranking of peptides used for weight loss: what half-life actually means, why a tiny chemical tweak turns a hormone that lasts minutes into a drug that lasts a week, how "steady state" works and why titration steps are spaced about a month apart, what Cmax and Tmax are, why the oral pill has its own strange rulebook, and why missing one weekly dose is forgiving while missing a daily one is not. For the full profile of any one molecule, including complete dosing charts, we link out to the dedicated guides, so this page stays a clean concept map.

Key Takeaways

  • Half-life is the time for the blood level of a drug to fall by half. Your body's own GLP-1 has a half-life of only about 1 to 2 minutes because the enzyme DPP-4 chops it up almost immediately (Drucker et al., Annals of Pediatric Endocrinology & Metabolism / PMC, 2017).
  • GLP-1 drugs are engineered to resist that breakdown and bind to blood albumin, stretching the half-life from minutes to days or a week so they can be dosed weekly instead of continuously. Semaglutide shares about 94% homology with native GLP-1 (StatPearls / NCBI, 2024).
  • Half-life sets the dosing schedule. Semaglutide's roughly 7-day half-life means weekly dosing; tirzepatide (~5 days) and dulaglutide (~5 days) are also weekly; liraglutide (~13 hours) is daily (FDA Ozempic label, 2023; FDA Mounjaro label, 2022; FDA Victoza label, 2017).
  • Steady state takes about 4 to 5 half-lives. For weekly semaglutide that is roughly 4 to 5 weeks, which is exactly why titration steps are held for about four weeks before stepping up (FDA Ozempic label, 2023).
  • Oral semaglutide (Rybelsus) keeps the long ~1-week half-life but is dosed daily because so little is absorbed; it relies on an absorption enhancer called SNAC and must be taken on an empty stomach (FDA Rybelsus label, 2025).
  • A missed weekly dose is forgiving because a 7-day half-life means levels barely dip between shots; semaglutide's label says a missed dose can be taken within 5 days, otherwise skip it (FDA Ozempic prescribing information / DailyMed, 2023).

What does "pharmacokinetics" actually mean?

Pharmacokinetics is the study of what your body does to a drug over time: how it is absorbed, spread around, broken down, and removed. A useful shorthand is ADME, for absorption, distribution, metabolism, and elimination. For GLP-1 drugs, the part that matters most to a reader is how long the drug lasts, because that determines how often you have to take it.

A row of three unbranded GLP-1 injection pens and a small medication vial on a clean clinical surface with a faint rising line graph behind them, illustrating how drug levels change over time.

In plain terms, pharmacokinetics is the timeline of a drug. It answers questions like how fast a dose gets into your blood, how high the level peaks, how long it stays, and how quickly it leaves. Pharmacology has a sister concept, pharmacodynamics, which is what the drug does to the body (lowering blood sugar, reducing appetite). This article is about the first one, the timing, because timing is the hidden logic behind every GLP-1 dosing schedule.

The whole reason a class of drugs that all copy the same gut hormone can be dosed so differently, from twice a day to once a week, comes down to a handful of PK numbers. We will build up from the most important one, the half-life, and use it to explain the rest. For the receptor-and-signaling side of the story, see how peptides work in the body.

Citation capsule. Pharmacokinetics (PK) describes a drug's time course in the body through absorption, distribution, metabolism, and elimination (ADME). For GLP-1 receptor agonists, the key PK parameters are the elimination half-life, the time to peak concentration (Tmax), the peak concentration (Cmax), and the time to steady state, which is reached after roughly four to five half-lives. Source: standard pharmacokinetic principles as applied in FDA prescribing information, 2022 to 2025.

What is a drug half-life, in plain English?

A half-life is simply the time it takes for the amount of drug in your blood to drop by half. If a drug has a one-week half-life, then a week after a dose, half is left; after two weeks, a quarter; after three weeks, an eighth, and so on. It is the single most useful number for understanding how often a drug needs to be taken and how long it lingers after you stop.

Think of it like a cup of coffee cooling on a desk: it loses heat fast at first, then more slowly, halving the gap to room temperature in even steps. Drugs clear the same way. A short half-life (minutes to hours) means the drug is gone quickly and must be re-dosed often to keep working. A long half-life (days) means the level changes slowly, so you can dose infrequently and a single missed dose barely moves the needle.

Two practical rules fall straight out of the half-life and explain most of what follows. First, it takes about four to five half-lives to clear a drug almost completely after the last dose. Second, by the same math, it takes about four to five half-lives of regular dosing to build up to a stable level when you start. Hold onto those two rules; they are the backbone of GLP-1 dosing schedules.

Why does natural GLP-1 last only minutes but the drugs last days?

Your body's own GLP-1 is destroyed within about one to two minutes by an enzyme called DPP-4, while GLP-1 drugs are deliberately engineered to dodge that enzyme and cling to blood proteins, which stretches their half-life from minutes to days or a week. That engineering is the entire reason a weekly injection is even possible.

Natural GLP-1 is released by your gut after a meal and is gone almost instantly, with a half-life of roughly 1 to 2 minutes, because the enzyme dipeptidyl peptidase-4 (DPP-4) clips it apart and the kidneys clear the fragments (Drucker et al., Annals of Pediatric Endocrinology & Metabolism / PMC, 2017, retrieved 2026-06-16). That is fine for a hormone meant to fire in short bursts, but useless as a medicine, since you cannot inject something every two minutes.

Drug designers fixed this with two main tricks. They changed the spots on the molecule that DPP-4 attacks, so the enzyme can no longer cut it, and they attached a fatty-acid chain that lets the drug bind tightly to albumin, the most common protein in your blood. Bound to albumin, the drug travels through the body as a slow-release reservoir, hidden from the enzymes and kidneys that would otherwise clear it. Semaglutide keeps about 94% of the structure of human GLP-1, so the receptor still recognizes it, but its half-life jumps to about a week (StatPearls / NCBI, "Semaglutide," 2024, retrieved 2026-06-16). The molecule is then broken down gradually by general protein-digesting processes rather than a single organ, which is why no specific liver or kidney step dominates its clearance (Mahapatra et al., Diabetes Therapy / Springer, 2020, retrieved 2026-06-16).

Our take: The most common misconception we see is that a weekly GLP-1 shot "works for a week" because of a slow-release coating, like a timed capsule. It is not a coating. The drug itself is chemically rebuilt to survive in the bloodstream and to hide on albumin, so the long action is baked into the molecule, not the delivery device.

Half-life across GLP-1 compounds and the dosing schedule it producesHalf-life sets the dosing scheduleApproximate elimination half-life. Bars use a compressed (log-like) scale so minutes and days both fit.Native GLP-1~2 min · (hormone)Exenatide IR~2.4 h · twice dailyLiraglutide~13 h · once dailyTirzepatide~5 d · weeklyDulaglutide~5 d · weeklySemaglutide~7 d · weeklyShorter half-life (top) means dose more often; longer half-life (bottom) means dose less often.Source: FDA labels for Victoza (2017), Mounjaro (2022), Trulicity (2020), Byetta; Ozempic (2023); native GLP-1 from PMC5401818, 2017.
The half-life ladder. From a hormone that lasts minutes to drugs that last days, the dosing frequency tracks the half-life almost perfectly.

What are the half-lives of the major GLP-1 drugs?

The major GLP-1 drugs run from a roughly 13-hour half-life (liraglutide, dosed daily) up to about 5 to 7 days (dulaglutide, tirzepatide, and semaglutide, all dosed weekly), and the dosing frequency tracks the half-life almost exactly. The longer the half-life, the less often you inject.

A translucent injection pen beside a left-to-right row of glowing blue droplets, each one half the size of the previous, illustrating the concept of a drug half-life.

Here is the at-a-glance map. These are the elimination half-lives published on each drug's FDA label or in peer-reviewed PK studies, not dosing instructions:

Drug (brand)Elimination half-lifeDosing frequencyRoute
Semaglutide (Ozempic, Wegovy)~7 days (about 1 week)Once weeklySubcutaneous injection
Tirzepatide (Mounjaro, Zepbound)~5 daysOnce weeklySubcutaneous injection
Dulaglutide (Trulicity)~5 daysOnce weeklySubcutaneous injection
Liraglutide (Victoza, Saxenda)~13 hoursOnce dailySubcutaneous injection
Oral semaglutide (Rybelsus)~1 weekOnce dailyOral tablet

The pattern is clean for the injectables. Semaglutide's half-life of about one week is why Ozempic and Wegovy are weekly shots (FDA Ozempic label, 2023, retrieved 2026-06-16). Tirzepatide sits at about 5 days, also comfortably weekly (FDA Mounjaro label, 2022, retrieved 2026-06-16). Dulaglutide is likewise about 5 days and weekly (FDA Trulicity label, 2020, retrieved 2026-06-16). Liraglutide, the older molecule, has a half-life of only about 13 hours, which is why Victoza and Saxenda are taken every day (FDA Victoza label, 2017, retrieved 2026-06-16).

The one row that looks like it breaks the pattern is oral semaglutide, and it is the interesting exception we unpack below. For the complete molecule-by-molecule profiles, including indications and dosing ladders, see the semaglutide guide, the tirzepatide guide, and the cross-class concept hub the GLP-1/GIP/glucagon triple-agonist explainer.

Why is oral GLP-1 (Rybelsus) dosed daily when its half-life is still a week?

Oral semaglutide is taken every day even though the molecule still has a one-week half-life, because so little of each tablet is absorbed that a daily dose is needed to keep enough drug in the body, and absorption only works on an empty stomach with the help of a built-in enhancer called SNAC. The half-life did not change; the absorption problem did.

Peptides like semaglutide are normally destroyed in the stomach, the same way your body digests protein from food. To get any of it through, Rybelsus is co-formulated with SNAC (sodium N-(8-(2-hydroxybenzoyl)amino)caprylate), an absorption enhancer that locally raises the pH and helps the peptide cross the stomach lining before it is broken down (Clinical Diabetes / American Diabetes Association, "Current Understanding of SNAC", 2024, retrieved 2026-06-16). Even with SNAC, only a small fraction is absorbed, and it is easily disrupted, so the tablet must be taken on an empty stomach with no more than a sip of plain water, then nothing else for at least 30 minutes (FDA Rybelsus label, 2025, retrieved 2026-06-16).

This is where the difference between two PK ideas matters. The molecule's half-life (about a week) governs how slowly it leaves once it is in your blood. But how much gets in from a tablet is so low and so variable that daily dosing is used to keep levels steady, rather than relying on one weekly tablet. Interestingly, an oral tablet reaches its peak blood level fast, with a Tmax of about 1 hour, far quicker than the injection's multi-day peak, which is another reason the absorption window has to be protected so carefully (FDA Rybelsus label, 2025, retrieved 2026-06-16). The brand-versus-form comparison is its own topic; this hub only explains the PK reason behind the daily pill.

What are Cmax and Tmax, and why do they matter?

Cmax is the highest blood level a dose reaches, and Tmax is how long it takes to get there; together they describe the shape of the peak after a dose. For weekly GLP-1 injections, the peak is slow and gentle, which is part of why side effects build gradually rather than hitting all at once.

After a subcutaneous semaglutide injection, the drug seeps into the blood slowly and reaches its peak (Tmax) only after about 1 to 3 days, then declines over the week (FDA Ozempic label, 2023, retrieved 2026-06-16). That slow, rounded peak is very different from a fast drug that spikes and crashes. Because the rise is gradual and the half-life is long, the difference between the peak (Cmax) and the trough right before the next dose is fairly small once you are at steady state, so blood levels stay in a relatively narrow band.

Why does this matter to a real person? Two reasons. First, a gentle, slow peak means the most common GLP-1 side effects, the digestive ones, tend to ramp up over a day or two after a dose increase rather than slamming you immediately. Second, the small peak-to-trough swing at steady state is part of why these drugs feel "even" across the week, with no dramatic on/off cycling. The fast 1-hour peak of the oral tablet behaves differently, which is one more reason the two forms are not interchangeable hour-for-hour.

How long does it take to reach steady state, and why are titration steps a month apart?

Steady state, the point where the amount going in each dose equals the amount clearing out so levels plateau, takes about 4 to 5 half-lives; for weekly semaglutide that is roughly 4 to 5 weeks, which is exactly why each titration step is held for about four weeks before increasing. The dosing calendar is just the half-life in disguise.

Seven small medication vials arranged in a rising staircase that levels off into a flat plateau, illustrating how repeated weekly doses build up to steady state.

When you start a weekly drug, you do not reach full blood levels after the first shot. Each weekly dose stacks a little on top of what remains from the previous ones, and the level climbs in steps until it plateaus. That plateau, steady state, arrives after about four to five half-lives. For semaglutide's roughly 7-day half-life, that is about 4 to 5 weeks, and the FDA label reflects this, noting steady state is reached after about four to five weeks of once-weekly dosing (FDA Ozempic label, 2023, retrieved 2026-06-16). Dulaglutide, with a similar profile, reaches steady state in roughly two to four weeks (FDA Trulicity label, 2020, retrieved 2026-06-16).

This is the hidden logic of the titration ladder. GLP-1 drugs are stepped up slowly (for example semaglutide's 0.25 mg starter, then 0.5 mg, then higher) and each step is typically held for about four weeks. That four-week hold is not arbitrary; it is roughly the time needed for the new dose to reach its own steady state so your body, and especially your gut, has fully adjusted before the next increase. Stepping up faster than the half-life allows is a common reason people feel worse than they need to. The full week-by-week ladders live in the per-drug dosing guides; here we only explain why the spacing exists.

Our take: People often ask why they "do not feel much" in the first couple of weeks on a new GLP-1 dose. That is steady state at work, not a dud dose. Levels are still climbing toward the plateau over four to five weeks, so judging a dose after one or two shots is judging it before it has fully arrived.

Reaching steady state: weekly dosing builds up over about 4 to 5 half-livesBuilding up to steady stateWeekly dose, ~1-week half-life. Blood level climbs each week, then plateaus. Illustrative shape.0levelsteady-state plateauwk 0wk 1wk 2wk 3wk 4wk 5wk 7wk 9Illustrative of the 4-to-5 half-life rule. Source: FDA Ozempic label, 2023 (steady state ~4-5 weeks).
Each weekly dose stacks on the last until intake equals clearance. The plateau (steady state) arrives after about four to five half-lives, which is why titration steps are held about a month.

What happens if I miss a dose? Why is a weekly GLP-1 "forgiving"?

Missing one weekly GLP-1 dose is forgiving because the long half-life means your blood level barely drops between shots, so a late dose hardly changes anything; missing a daily drug like liraglutide matters more because levels fall fast within a day. The longer the half-life, the more slack the schedule has.

Run the half-life math. With semaglutide's roughly 7-day half-life, you still have about half the drug in your system a full week after a dose, so taking a weekly shot a day or two late only nudges the level slightly. Reflecting this, the FDA labeling for once-weekly semaglutide advises that a missed dose can be taken as soon as possible within 5 days of the scheduled day; if more than five days have passed, you skip it and resume the normal weekly schedule (FDA Ozempic prescribing information / DailyMed, 2023, retrieved 2026-06-16). That five-day grace window exists precisely because the half-life is long. Always follow the specific guidance for your own product and clinician; missed-dose rules vary by drug.

Contrast that with a daily drug. Liraglutide's roughly 13-hour half-life means a large fraction clears every day, so a single missed daily dose lets the level sag noticeably, and the next dose has to start rebuilding. This is the everyday upside of long-half-life GLP-1 drugs: the schedule is hard to derail. It is also why these drugs keep working for weeks after the last dose, and why appetite and blood sugar effects fade slowly rather than vanishing overnight when someone stops.

Why a missed weekly dose is forgiving: slow decay versus fast decaySlow decay is a forgiving scheduleSingle dose, then no more. Percent of the dose remaining over 14 days. Illustrative.100%50%0%~50% left at day 7weekly (~7-day t½)daily (~13-h t½)day 0day 3day 7day 14Illustrative decay shapes. Half-lives: semaglutide ~7 d (FDA Ozempic, 2023); liraglutide ~13 h (FDA Victoza, 2017).
A weekly drug still has roughly half its dose on board a week later, so a late dose barely matters. A daily drug clears within a day, so a missed dose is felt sooner.

How is GLP-1 cleared from the body, and how long until it is gone?

GLP-1 drugs are broken down gradually into small fragments by the body's general protein-handling machinery rather than removed by one organ, and after the last dose it takes about 4 to 5 half-lives to clear almost completely. For weekly semaglutide that means roughly five weeks until it is essentially gone.

Unlike many small-molecule drugs that lean heavily on the liver or kidneys, the long-acting GLP-1 peptides are largely metabolized by proteolysis, meaning enzymes throughout the body slowly cleave the peptide into smaller pieces, with the leftovers excreted in both urine and feces (Mahapatra et al., Diabetes Therapy / Springer, 2020, retrieved 2026-06-16). Because no single organ dominates, these drugs tend to be more forgiving across different patients than drugs that depend on one clearance pathway, though clinicians still account for individual factors.

The "how long until it is gone" question is just the half-life rule run forward. After the last dose, half is gone in one half-life, and after about four to five half-lives the drug is down to a few percent and considered essentially cleared. For semaglutide (about a 7-day half-life) that is roughly five weeks; for tirzepatide and dulaglutide (about 5 days) it is closer to three to four weeks; for liraglutide (about 13 hours) it is only a couple of days. This is also why effects, both wanted and unwanted, taper off slowly rather than stopping the moment you take the last dose. The practical "how long does it stay in your system" version of this question is in the FAQ below.

Frequently Asked Questions

A half-life is the time it takes for the amount of a drug in your blood to fall by half. If a drug has a one-week half-life, half remains after one week, a quarter after two weeks, and so on. It is the key number for understanding how often a drug must be dosed and how long it lingers after the last dose.

The bottom line

Almost everything that looks arbitrary about GLP-1 dosing schedules turns out to be pharmacokinetics in disguise. Your body's own GLP-1 vanishes in a minute or two because an enzyme shreds it; the drugs last days to a week because they are engineered to dodge that enzyme and ride along on blood albumin. That one change, from a minutes-long half-life to a roughly one-week half-life for semaglutide, is the reason Ozempic is weekly, why it takes about a month to reach steady state, why titration steps are held about four weeks, and why a late weekly dose barely registers.

If you remember one idea, make it the half-life. It explains the weekly versus daily split (semaglutide, tirzepatide, and dulaglutide last days; liraglutide lasts hours), the four-to-five-week climb to steady state, the slow taper after stopping, and the forgiving missed-dose window. The oral pill is the lone twist, where an absorption problem, not the half-life, forces daily dosing. From here, the natural next reads are the full molecule profiles, semaglutide, tirzepatide, retatrutide, and orforglipron, plus the mechanism foundations in how peptides work. And for any decision about these medicines, talk to a qualified clinician.

Sources